Identity on this record
Chemical name: Tesamorelin.
Common synonyms: TH9507, GHRH analog peptide.
CAS number: 218949-48-5 (registry entry).
Structural class: Growth hormone-releasing hormone analog.
Appearance: White lyophilised powder.
Catalog strengths: 5 mg and 10 mg vials.
Those identifiers describe Tesamorelin as a substance. They do not describe a particular vial. The vial is identified by the name, the nominal fill, and the lot number on its label, checked against the published certificate.
What the catalogue actually sells
Tesamorelin 5mg is the 5 mg lyophilized unit, listed at AED 399 before VAT. The product record stores that sealed unit at 2–8 °C · protect from light. Tesamorelin 10mg is the 10 mg lyophilized unit, listed at AED 549 before VAT. The product record stores that sealed unit at 2–8 °C · protect from light.
Prices are merchandise prices in AED, exclusive of VAT. VAT is added at checkout. A price on this summary is the figure on the product record for Tesamorelin, not a delivered-cost quote.
Lots and certificates
Lot VL-TESA-20260801 is the catalogue certificate for Tesamorelin 5mg. Read it on Tesamorelin 5mg certificate and match the vial in batch verification. A certificate for a different strength, or for a blend that merely contains the same name, does not release this unit.
Lot VL-TESA10-20260917 is the catalogue certificate for Tesamorelin 10mg. Read it on Tesamorelin 10mg certificate and match the vial in batch verification. A certificate for a different strength, or for a blend that merely contains the same name, does not release this unit.
How the compound record describes the literature
Tesamorelin (TH9507) was characterised as a stabilised GHRH analog; pharmaceutical products exist under specific indications in some markets — VaultLabs research material is not that finished medicine.
Topics named on the Tesamorelin record, as literature context rather than as outcomes VaultLabs claims: GHRH receptor binding assays; Pituitary secretagogue model systems; Comparative GHRH analog analytics.
That is context for identifying Tesamorelin. It is not a claim that a vial produces a result in a person, an animal, or a study VaultLabs has not published. VaultLabs does not provide dosage, administration, study-design, or medical guidance.
Points the monograph already states
Points already written on the Tesamorelin monograph, so a reader can check them against that page:
Stabilised GHRH analog; literature CAS registry number 218949-48-5.
Development designation TH9507 appears in early characterisation literature.
Catalog presentations are 5 mg and 10 mg lyophilised research material.
Distinct from CJC-1295 / Ipamorelin blend SKUs — different sequences and lots.
Not for human or veterinary use.
Dispatch and the research-use boundary
VaultLabs dispatches Tesamorelin from Dubai. Orders leave fulfillment within 24 hours, 7 days a week. Standard delivery is AED 35 to every emirate, and delivery is free when the post-discount merchandise subtotal is AED 500 or more. Checkout shows the fee for the address entered. All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use. VaultLabs does not provide dosage, administration, study-design, or medical guidance.
The full narrative record is the Tesamorelin compound monograph. Handling of the sealed unit is the Tesamorelin storage guide. Questions are collected on the Tesamorelin FAQ. How it differs from neighbouring records is the Tesamorelin comparison.